RFA-OH-26-016: Extension of the World Trade Center Health Registry (U50)
Closed
This grant is closed. A newer notice from the same program is open now: Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21) (RFA-OH-26-015). Status: Closes December 8, 2026 (31 days left). It is in our archive of Centers for Disease Control and Prevention - ERA notices from 2025.
Centers for Disease Control and Prevention - ERA offered grants of up to $9.5 million to any type of organization. It expected to make one award worth $47.4 million in total. Applications closed on February 20, 2026.
From the official notice on Grants.gov, last changed January 5, 2026. Checked November 7, 2026.
- Award ceiling$9.5 million
- Total funding$47.4 million
- Expected awards1
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | December 19, 2025 |
|---|---|
| Deadline | February 20, 2026 |
| Archived by Grants.gov | March 20, 2026 |
Who can apply
This opportunity was open to any type of organization.
All 14 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the HHS Grants Policy Statement, are not allowed.
Is this a realistic fit?
- Past Occupational Safety and Health Program awards averaged $1.9 million; this notice allows up to $9.5 million per award.
- No cost sharing or match is required.
What the grant funds
In 2002, the Agency for Toxic Substances and Disease Registry (ATSDR) and the New York City Health Department established the World Trade Center (WTC) Health Registry with the goal of monitoring the health of people directly exposed to the 9/11 WTC disaster. The purpose of this announcement is to solicit meritorious and scientifically rigorous research applications that address the James Zadroga 9/11 Health and Compensation Act mandate to extend the Registry developed and managed by the New York City Department of Health and Mental Hygiene in a cooperative agreement with the Centers for Disease Control and Prevention (CDC). This will ensure ongoing data collection for victims of the September 11, 2001, terrorist attacks on the WTC. The WTC Health Registry will continue to provide a central, unified database to assess long-term health and well-being effects among persons exposed to the 9/11 WTC disaster. The Registry identifies long-term physical and mental health effects of the 9/11 WTC disaster; disseminates findings and recommendations to enrollees and others exposed, the public, and the scientific community; shares information about 9/11 related resources and services; and informs healthcare policy and disaster response planning.
Who has won Occupational Safety and Health Program grants before
From fiscal 2021 to 2025, Occupational Safety and Health Program (93.262) awarded $590 million across 305 grant awards, an average of $1.9 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| City of New York | New York | 1 | $39.5 million |
| CPWR: the Center for Construction Research and Training | Maryland | 2 | $27.2 million |
| The University of Iowa | Iowa | 5 | $23.6 million |
| University of Illinois | Illinois | 5 | $21.2 million |
| Icahn School of Medicine at Mount Sinai | New York | 16 | $18.9 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, RFA-OH-26-015, which is open now.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is RFA-OH-26-016 still open?
No. It closed on February 20, 2026. A newer notice is open: RFA-OH-26-015, closes December 8, 2026 (31 days left).
Who can apply for Extension of the World Trade Center Health Registry (U50)?
Centers for Disease Control and Prevention - ERA accepted applications from any type of organization. The notice adds further conditions, so read its eligibility section.
What is the deadline for Extension of the World Trade Center Health Registry (U50)?
Closed February 20, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $9.5 million each. About $47.4 million in total for one award.
Who has won Occupational Safety and Health Program grants before?
The largest recipients over five fiscal years were City of New York, CPWR: the Center for Construction Research and Training, The University of Iowa. The program made 305 awards worth $590 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)